GETINGE EBITDA Margin 2016-2024 | GNGBY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for GETINGE (GNGBY) over the last 10 years. The current EBITDA margin for GETINGE as of September 30, 2024 is .
| GETINGE EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $3.21B | $0.48B | 14.99% |
| 2024-06-30 | $3.16B | $0.59B | 18.54% |
| 2024-03-31 | $3.04B | $0.54B | 17.69% |
| 2023-12-31 | $3.00B | $0.55B | 18.32% |
| 2023-09-30 | $2.87B | $0.54B | 18.62% |
| 2023-06-30 | $2.83B | $0.51B | 17.89% |
| 2023-03-31 | $2.83B | $0.56B | 19.82% |
| 2022-12-31 | $2.80B | $0.56B | 20.01% |
| 2022-09-30 | $2.91B | $0.59B | 20.28% |
| 2022-06-30 | $2.98B | $0.62B | 20.90% |
| 2022-03-31 | $3.08B | $0.68B | 22.20% |
| 2021-12-31 | $3.15B | $0.72B | 22.86% |
| 2021-09-30 | $3.25B | $0.78B | 23.89% |
| 2021-06-30 | $3.42B | $0.89B | 26.00% |
| 2021-03-31 | $3.36B | $0.85B | 25.26% |
| 2020-12-31 | $3.25B | $0.79B | 24.30% |
| 2020-09-30 | $3.13B | $0.80B | 25.65% |
| 2020-06-30 | $2.89B | $0.59B | 20.28% |
| 2020-03-31 | $2.83B | $0.52B | 18.45% |
| 2019-12-31 | $2.81B | $0.49B | 17.34% |
| 2019-09-30 | $2.81B | $0.43B | 15.26% |
| 2019-06-30 | $2.79B | $0.22B | 7.92% |
| 2019-03-31 | $2.79B | $0.22B | 7.93% |
| 2018-12-31 | $2.78B | $0.18B | 6.36% |
| 2018-09-30 | $2.14B | $0.12B | 5.65% |
| 2018-06-30 | $2.33B | $0.29B | 12.44% |
| 2018-03-31 | $2.49B | $0.22B | 8.66% |
| 2017-12-31 | $2.64B | $0.25B | 9.36% |
| 2017-09-30 | $3.46B | $0.28B | 8.03% |
| 2017-06-30 | $3.45B | $0.25B | 7.31% |
| 2017-03-31 | $3.47B | $0.29B | 8.41% |
| 2016-12-31 | $3.48B | $0.27B | 7.71% |
| 2016-09-30 | $3.52B | $1.21B | 34.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.288B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |